Yi Yi Chen
Director/Board Member chez SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD.
Fortune : 6 M $ au 31/03/2024
Profil
Yi Yi Chen is currently an Executive Director at Shanghai Haohai Biological Technology Co., Ltd., a Director at Shenzhen New Industries Material of Ophthalmology Co., Ltd., a Director at Shanghai Hengtai Vision Technology Co., Ltd., and a Member-Supervisory Board at Henan Universe Intraocular Lens R&M Co., Ltd.
Previously, Ms. Chen worked as a Marketing Manager at Shanghai Haohai Chemical Co. Ltd.
Ms. Chen received an undergraduate degree from Huazhong University of Science & Technology in 2004 and a graduate degree from the same university in 2006.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/03/2024 | 424 260 ( 0,36% ) | 6 M $ | 31/03/2024 |
Postes actifs de Yi Yi Chen
| Sociétés | Poste | Début |
|---|---|---|
| SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD. | Director/Board Member | 01/07/2010 |
Shenzhen New Industries Material of Ophthalmology Co., Ltd.
 Shenzhen New Industries Material of Ophthalmology Co., Ltd. Medical SpecialtiesHealth Technology Shenzhen New Industries Material of Ophthalmology Co., Ltd. engages in the technology development of medical products. It focuses on ophthalmic equipment and ophthalmic device. Its products include fundus slice imaging system Regional Health Authority (RHA), emulsification and vitrectomy equipment R-Evolution CR, model 30 eumatonometer, Tetraflex HD—Aspherical accommodating intraocular lens (IOL), segmental bifocal lens, Tetraflex IOL, Softec HDO Equiconvex Bi-aspheric IOL, Softec HD aspheric IOL, Softec I Foldable Posterior Chamber IOL, OASIS iris expander, healaflow, and ophteisbio. The company was founded on April 27, 2006 and is headquartered in Shenzhen, China. | Director/Board Member | 01/11/2016 |
Henan Universe Intraocular Lens R&M Co., Ltd.
 Henan Universe Intraocular Lens R&M Co., Ltd. Electronic ComponentsElectronic Technology Henan Universe Intraocular Lens R&M Co., Ltd. engages in the production and sales of ophthalmic medical device products. Its products include hydrophilic foldable, polymethylmethacrylate (PMMA), and anterior chamber polymethylmethacrylate intraocular lens. The firm also offers intraocular injection system, viscoelastics, glaucoma drainage implants, and surgical suture products. The company was founded on April 23, 1991 and is headquartered in Zhengzhou, China. | Director/Board Member | 01/11/2016 |
Shanghai Hengtai Vision Technology Co., Ltd.
 Shanghai Hengtai Vision Technology Co., Ltd. Medical/Nursing ServicesHealth Services Part of Shanghai Haohai Biological Technology Co., Ltd., Shanghai Hengtai Vision Technology Co., Ltd. is a brand that provides comprehensive solutions for "vision protection and eye health" for children and teenagers. The private company is based in Shanghai, China. Shanghai Hengtai Vision Technology Co. was acquired by Shanghai Haohai Biological Technology Co., Ltd. on April 21, 2021 for $3.85 million. The Chinese company offers personalized myopia correction, vision correction, and children's eyeglass lenses that cater to the eye habits of Asian children and teenagers. The company was founded in 2017, and the CEO is Guan Han Wu. | Director/Board Member | - |
Anciens postes connus de Yi Yi Chen
| Sociétés | Poste | Fin |
|---|---|---|
| Shanghai Haohai Chemical Co. Ltd. | Sales & Marketing | 01/12/2009 |
Formation de Yi Yi Chen
| Huazhong University of Science & Technology | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD. | Distribution Services |
| Entreprise privées | 4 |
|---|---|
| Shanghai Haohai Chemical Co. Ltd. | |
Henan Universe Intraocular Lens R&M Co., Ltd.
Henan Universe Intraocular Lens R&M Co., Ltd. Electronic ComponentsElectronic Technology Henan Universe Intraocular Lens R&M Co., Ltd. engages in the production and sales of ophthalmic medical device products. Its products include hydrophilic foldable, polymethylmethacrylate (PMMA), and anterior chamber polymethylmethacrylate intraocular lens. The firm also offers intraocular injection system, viscoelastics, glaucoma drainage implants, and surgical suture products. The company was founded on April 23, 1991 and is headquartered in Zhengzhou, China. | Electronic Technology |
Shenzhen New Industries Material of Ophthalmology Co., Ltd.
Shenzhen New Industries Material of Ophthalmology Co., Ltd. Medical SpecialtiesHealth Technology Shenzhen New Industries Material of Ophthalmology Co., Ltd. engages in the technology development of medical products. It focuses on ophthalmic equipment and ophthalmic device. Its products include fundus slice imaging system Regional Health Authority (RHA), emulsification and vitrectomy equipment R-Evolution CR, model 30 eumatonometer, Tetraflex HD—Aspherical accommodating intraocular lens (IOL), segmental bifocal lens, Tetraflex IOL, Softec HDO Equiconvex Bi-aspheric IOL, Softec HD aspheric IOL, Softec I Foldable Posterior Chamber IOL, OASIS iris expander, healaflow, and ophteisbio. The company was founded on April 27, 2006 and is headquartered in Shenzhen, China. | Health Technology |
Shanghai Hengtai Vision Technology Co., Ltd.
Shanghai Hengtai Vision Technology Co., Ltd. Medical/Nursing ServicesHealth Services Part of Shanghai Haohai Biological Technology Co., Ltd., Shanghai Hengtai Vision Technology Co., Ltd. is a brand that provides comprehensive solutions for "vision protection and eye health" for children and teenagers. The private company is based in Shanghai, China. Shanghai Hengtai Vision Technology Co. was acquired by Shanghai Haohai Biological Technology Co., Ltd. on April 21, 2021 for $3.85 million. The Chinese company offers personalized myopia correction, vision correction, and children's eyeglass lenses that cater to the eye habits of Asian children and teenagers. The company was founded in 2017, and the CEO is Guan Han Wu. | Health Services |
